These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 4272834)
1. Specificity of antibodies that inhibit the MLC response. Thorsby E; Solheim BG Transplant Proc; 1973 Dec; 5(4):1859-62. PubMed ID: 4272834 [No Abstract] [Full Text] [Related]
2. [Inhibitory effect on lymphocyte transformation of anti-HL-A sera]. Pospísil M; Meo T; Carbonara AO; Ceppellini R G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1970; 63(11):860-74. PubMed ID: 5524311 [No Abstract] [Full Text] [Related]
3. Genetic analysis and biological properties of products of the third SD (AJ) locus of the HL-A region. Mayr WR; Bernoco D; De Marchi M; Ceppellini R Transplant Proc; 1973 Dec; 5(4):1581-93. PubMed ID: 4130068 [No Abstract] [Full Text] [Related]
4. [The specificity of leukocyte antibodies in histocompatibility testing of serum from prima- and multiparas]. Bertrams J; Kuwert E; Lohmeyer HH Bibl Haematol; 1971; 37():98-106. PubMed ID: 5138931 [No Abstract] [Full Text] [Related]
5. Inhibition of lymphocyte proliferative responses by anti-HL-A alloantisera. Brochier J; Roitt IM; Festenstein H Eur J Immunol; 1974 Nov; 4(11):709-15. PubMed ID: 4279178 [No Abstract] [Full Text] [Related]
6. The HL-A system. I. Genetics and molecular biology. Ceppellini R; van Rood JJ Semin Hematol; 1974 Jul; 11(3):233-51. PubMed ID: 4151844 [No Abstract] [Full Text] [Related]
7. Autologous plasma affecting the maternal response in mixed lymphocyte cultures with the newborn. Imre G; Petri I; Keserü TL; Obál M Haematologia (Budap); 1973; 7(2):193-8. PubMed ID: 4275101 [No Abstract] [Full Text] [Related]
8. The human major histocompatibility system. Thorsby E Transplant Rev; 1974; 18():51-129. PubMed ID: 4141523 [No Abstract] [Full Text] [Related]
9. Antibody-dependent lymphocyte-mediated cytotoxicity in an allogeneic human system. II. Evidence for HL-A specificity. Dickmeiss E; Nielsen LS Scand J Immunol; 1974; 3(2):199-207. PubMed ID: 4822686 [No Abstract] [Full Text] [Related]
10. [Specificity of lymphocytotoxic antibodies. Serologic and chemical characteristics. Effect of autoantibodies on mixed lymphocyte culture (MLC) and lymphocyte culture]. Malchow H; Horstkamp B; JohannsenR ; Schmidt W; Havemann K Verh Dtsch Ges Inn Med; 1974; 80():1623-7. PubMed ID: 4281578 [No Abstract] [Full Text] [Related]
11. Heterologous antisera for human histocompatibility testing. Balner H; Gabb BW; Dersjant H; Van Vreeswijk W; Van Leeuwen A; Van Rood JJ Transplant Proc; 1971 Jun; 3(2):1088-98. PubMed ID: 4944049 [No Abstract] [Full Text] [Related]
12. Mixed lymphocyte culture (MLC) inhibition in humans due to anti-Ia like (DRW). Soulillou JP; Naud MF; Peyrat MA; Guenel J Pathol Biol (Paris); 1978 Dec; 26(9-10):547-51. PubMed ID: 154642 [TBL] [Abstract][Full Text] [Related]
13. Serotyping for MLC gene products. II. ABCIL detection of HLA-D specificities by the "tandem" technique, using multiparous sera before and after absorption with HLA-D homozygous lymphocytes. Kovithavongs T; Marchuk L; Schlaut J; Dossetor JB Transplant Proc; 1977 Mar; 9(1):445-9. PubMed ID: 141131 [No Abstract] [Full Text] [Related]
15. The immunologic specificity and biologic activity of heterologous anti-human sera. I. Properties of rabbit anti-human fibroblast sera. Bachvaroff R; Rapaport FT J Immunol; 1972 Nov; 109(5):1081-9. PubMed ID: 4627932 [No Abstract] [Full Text] [Related]
16. [Demonstration of lymphocytotoxic antibodies directed against A and B antigens and against non HL-A histocompatibility antigens. Preliminary communication]. Jeannet M; Schapira M; Magnin C Schweiz Med Wochenschr; 1974 Jan; 104(4):152. PubMed ID: 4590411 [No Abstract] [Full Text] [Related]
17. HL-A antibodies in chimpanzees after specific treatment with human leukocytes and antihuman lymphocyte globulin. Johannsen R; Seiler FR Transplant Proc; 1972 Mar; 4(1):77-81. PubMed ID: 5011649 [No Abstract] [Full Text] [Related]
18. Effects of alloantibodies on lymphocyte proliferation in vitro. Revillard JP; Betuel H; Robert M Cell Immunol; 1973 Sep; 8(3):339-55. PubMed ID: 4269399 [No Abstract] [Full Text] [Related]
19. The use of human F(ab') 2 fragments as blocking agents in the mixed lymphocyte reaction. Hornung MO; Layne E; McDonald JC J Immunol; 1971 Oct; 107(4):979-84. PubMed ID: 4999263 [No Abstract] [Full Text] [Related]
20. Joint report of 1st International Workshop on Canine Immunogenetics. Vriesendorp HM; Westbroek DL; D'Amaro J; van der Does JA; van der Steen GJ; van Rood JJ; Albert E; Bernini L; Bull RW; Cabasson J; Epstein RB; Erikson V; Feltkamp TE; Flad HD; Hammer C; Lang R; Largiadér F; von Loringhoven K; Los W; Meera Khan P; Saison R; Serrou B; Schnappauf H Tissue Antigens; 1973; 3(2):145-63. PubMed ID: 4274159 [No Abstract] [Full Text] [Related] [Next] [New Search]